Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection

Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection

Abstract Long-term effect of Direct-acting antivirals (DAAs) on gut microbiota, short-chain fatty acids (SCFAs) and microbial translocation in patients with hepatitis C virus (HCV) infection who achieve sustained virological response (SVR) were limited. A longitudinal study of 50 patients with HCV m...

Full description

Bibliographic Details
Main Authors: Natthaya Chuaypen, Thananya Jinato, Anchalee Avihingsanon, Intawat Nookaew, Yasuhito Tanaka, Pisit Tangkijvanich
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-41664-7

Internet

https://doi.org/10.1038/s41598-023-41664-7

Similar Items